Chronic wasting disease as a model for human prion therapy

Area of Science:

• Neurodegenerative diseases
• Veterinary medicine
• Prion science

Background:

• Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative conditions caused by misfolded prion proteins.
• These disorders manifest in sporadic, acquired, or genetic forms, affecting various animal species like sheep (scrapie), cattle (bovine spongiform encephalopathy), and cervids (chronic wasting disease).
• Chronic wasting disease (CWD) is notable for its prevalence in free-ranging wildlife populations.

Purpose of the Study:

• To propose Chronic Wasting Disease (CWD) as a relevant model for testing novel prion disease therapies.
• To highlight the potential of CWD as a testing ground for therapies aimed at preventing and treating prion diseases in humans.
• To underscore the ethical imperative of reducing animal suffering by managing CWD in cervid populations.

Main Methods:

• Review of existing literature on prion diseases and therapeutic approaches.
• Analysis of Chronic Wasting Disease (CWD) as a naturally occurring prion disease in wildlife.
• Consideration of novel therapeutic strategies, including prion protein expression modulation.

Main Results:

• No documented cases of Chronic Wasting Disease (CWD) transmission to humans exist, but the potential for adaptation remains.
• Novel therapeutic strategies for prion diseases, such as reducing prion expression, are under development.
• Chronic Wasting Disease (CWD) presents a unique opportunity to evaluate these therapies in natural settings.

Conclusions:

• Chronic Wasting Disease (CWD) should be considered a valuable model for testing prion disease therapies outside controlled laboratory conditions.
• Managing CWD in cervid populations is crucial for alleviating animal suffering and reducing the risk of interspecies transmission.
• Successful CWD management can mitigate future risks of transmission to humans and other animal species.